NeuroGeneces, Inc.
Biotechnology company · Santa Fe, New Mexico, United States
NeuroGeneces, Inc. is a biotechnology company headquartered in Santa Fe, New Mexico, United States. Its earliest recorded incorporation is in 2021. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $295,000 in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $425,000 sold in a notice filed in 2026.
NeuroGeneces at a glance
What does NeuroGeneces do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $295,000 in total (2023). NIH funding came from the National Institute on Aging.
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $425,000 sold (2026).
Frequently asked questions about NeuroGeneces
Where is NeuroGeneces headquartered?
NeuroGeneces, Inc. is headquartered in Santa Fe, New Mexico, United States.
What does NeuroGeneces do?
NeuroGeneces, Inc. is a biotechnology company.
When was NeuroGeneces founded?
The earliest incorporation on record for NeuroGeneces, Inc. is in 2021, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences